April 25, 2023 FDA Accelerated Approval of Tofersen Highlights Importance of Blood Neurofilament Light Chain as Surrogate Endpoint in Neurology Therapeutic Trials read more
March 6, 2023 Quanterix Releases Operating Results for Fourth Quarter and Full Year 2022; Aligned with Expectations read more
February 24, 2023 Quanterix Fourth Quarter Earnings and Full Year 2022 Financial Results Conference Call read more
January 9, 2023 Quanterix Expands Laboratory Developed Test Menu with Launch of Neurofilament Light Chain Test read more